Unexpectedly, we observed a rescue of motor behaviour and a marked prolongation of life expectancy following combined GCase and ASM deficiency, despite clear evidence of an additive effect on the intracellular level of key sphingolipids and their metabolites. This evidence concerns the gene SMPD1 and hyperinsulinemic hypoglycemia, familial, 4.